The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index
Registrars:
Capita Registrars
Key Personnel
Non-Executive Director:
Geoffrey C Hsu, Julie Tankard
Non-Executive Chairman:
Roger Yates
Senior Independent Director:
Hamish Baillie
Independent Non-Executive Director:
Julia Le Blan, Nicola Shepherd, Lord David Willetts